🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Researchers are looking for new ways to treat Limited-Stage Small Cell Lung...
Status
Active Not Recruiting
Location
Ironwood Cancer & Research Centers ( Site 0007)
Start Date
2020-12-08
Trial ID
NCT04624204
This is a Phase III randomised, double-blind, multi-centre study to evaluat...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-01-04
Trial ID
NCT03737643
Treatments Being Tested
A study to assess the efficacy and safety of durvalumab in combination with...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-05-05
Trial ID
NCT04269200
Treatments Being Tested
Study Title: A Multicenter, Randomized Controlled Trial of Tiaoshen Anti-ca...
Status
Not Yet Recruiting
Location
Shanghai Hospital of Traditional Chinese Medicine
Start Date
2026-05-01
Trial ID
NCT07550205
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following...
Status
Active Not Recruiting
Location
Clearview Cancer Institute
Start Date
2013-08-26
Trial ID
NCT01844986
Treatments Being Tested
This phase II trial investigates how well the addition of olaparib followin...
Status
Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2021-06-22
Trial ID
NCT04858334
The current study will compare pembrolizumab (MK-3475) plus maintenance ola...
Status
Completed
Location
Alabama Oncology Bruno Cancer Center ( Site 0001)
Start Date
2019-06-28
Trial ID
NCT03976362
Treatments Being Tested
A Phase II, Randomized, Multi-Center, Double-Blind, Comparative Global Stud...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-03-16
Trial ID
NCT03459846
Treatments Being Tested
This is a randomized, double-blind, multi-center, global Phase II study to ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-12-21
Trial ID
NCT03775486